{"id":501628,"date":"2021-06-08T07:04:33","date_gmt":"2021-06-08T11:04:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/"},"modified":"2021-06-08T07:04:33","modified_gmt":"2021-06-08T11:04:33","slug":"acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/","title":{"rendered":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021<\/b><\/p>\n<p class=\"bwalignc\"><i>&#8211; Event to be webcast on Tuesday, June 22 at 8:00 a.m. EDT &#8211;<\/i><\/p>\n<p>CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAcceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced it will host a Virtual R&amp;D Day for analysts and investors on June 22, 2021. The virtual event will take place from 8:00 a.m. to approximately 11:00 a.m. EDT.\n<\/p>\n<p>\nMembers of the Acceleron leadership team, along with external experts, will review the Company\u2019s numerous ongoing and planned trials in rare pulmonary diseases, and highlight Acceleron\u2019s vision and strategy for long-term growth.\n<\/p>\n<p><b>Guest Presenters: <\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMardi Gomberg-Maitland<sup>1<\/sup>, M.D., MSc<b>, <\/b>Professor of Medicine and Director of the George Washington University Hospital Pulmonary Hypertension Program\n<\/li>\n<li>\nMarc Humbert<sup>1<\/sup>, M.D., Ph.D., Professor of Medicine and Director of the French Pulmonary Hypertension Reference Center at the Universit\u00e9 Paris-Saclay\n<\/li>\n<li>\nVallerie McLaughlin<sup>1<\/sup>, M.D., Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Michigan\n<\/li>\n<\/ul>\n<p>\nA live webcast of the presentation and question and answer sessions will be accessible under \u201cEvents &amp; Presentations\u201d in the Investors &amp; Media page of the Company\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Facceleronpharma.com%2F&amp;esheet=52441545&amp;newsitemid=20210608005186&amp;lan=en-US&amp;anchor=www.acceleronpharma.com&amp;index=1&amp;md5=6b514ec4281ddb5ce3ae25ff3a71e751\">www.acceleronpharma.com<\/a>. To register for the event, please visit the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevent.webcasts.com%2Fstarthere.jsp%3Fei%3D1468007%26tp_key%3D5de6f183bd&amp;esheet=52441545&amp;newsitemid=20210608005186&amp;lan=en-US&amp;anchor=R%26amp%3BD+Day+2021+Registration+Site&amp;index=2&amp;md5=e7a9b71d1d9f764c005536a7831e1216\">R&amp;D Day 2021 Registration Site<\/a>.\n<\/p>\n<p>\nAn archived recording of the webcast will be available for replay on the Company\u2019s website beginning approximately two hours after the event.\n<\/p>\n<p><i><sup>1<\/sup>Drs. Gomberg, Humbert, and McLaughlin are investigators in multiple ongoing and planned Acceleron-sponsored clinical trials and are paid consultants to Acceleron. <\/i><\/p>\n<p><b>About Acceleron<\/b><\/p>\n<p>\nAcceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron\u2019s leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body&#8217;s ability to regulate cellular growth and repair.\n<\/p>\n<p>\nAcceleron focuses its research, development, and commercialization efforts in pulmonary and hematologic diseases. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension (PAH), having reported positive topline results of the PULSAR Phase 2 trial. The Company is currently planning multiple Phase 3 trials with the potential to support its long-term vision of establishing sotatercept as a backbone therapy for patients with PAH at all stages of the disease. Acceleron is also investigating the potential of its early-stage pulmonary candidate, ACE-1334, which it plans to advance into a Phase 1b\/Phase 2 trial in systemic sclerosis-associated interstitial lung disease (SSc-ILD) this year.\n<\/p>\n<p>\nIn hematology, REBLOZYL<sup>\u00ae<\/sup> (luspatercept-aamt) is the first and only erythroid maturation agent approved in the United States, Europe, and Canada for the treatment of anemia in certain blood disorders. REBLOZYL is part of a global collaboration partnership with Bristol Myers Squibb. The Companies co-promote REBLOZYL in the United States and are also developing luspatercept for the treatment of anemia in patient populations of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis.\n<\/p>\n<p>\nFor more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Facceleronpharma.com%2F&amp;esheet=52441545&amp;newsitemid=20210608005186&amp;lan=en-US&amp;anchor=www.acceleronpharma.com&amp;index=3&amp;md5=599fd0877245d0b1db1e1e83de47493b\">www.acceleronpharma.com<\/a>. Follow Acceleron on Social Media: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FAcceleronPharma&amp;esheet=52441545&amp;newsitemid=20210608005186&amp;lan=en-US&amp;anchor=%40AcceleronPharma&amp;index=4&amp;md5=78a2ce713650aa166c82827628344cd3\">@AcceleronPharma<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Facceleron-pharma%2F&amp;esheet=52441545&amp;newsitemid=20210608005186&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=4caaa6d272c92f4e24184493c58dd40a\">LinkedIn<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210608005186\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210608005186\/en\/<\/a><\/span><\/p>\n<p>\nAcceleron Pharma Inc.\n<\/p>\n<p>\nInvestors:<br \/>\n<br \/>Jamie Bernard, IRC, 617-301-9650<br \/>\n<br \/>Associate Director, Investor Relations\n<\/p>\n<p>\nMedia:<br \/>\n<br \/>Matt Fearer, 617-301-9557<br \/>\n<br \/>Senior Director, Corporate Communications\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health General Health Clinical Trials Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210608005186\/en\/883428\/3\/Acceleron_Logo_Jan2021_%281%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 &#8211; Event to be webcast on Tuesday, June 22 at 8:00 a.m. EDT &#8211; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced it will host a Virtual R&amp;D Day for analysts and investors on June 22, 2021. The virtual event will take place from 8:00 a.m. to approximately 11:00 a.m. EDT. Members of the Acceleron leadership team, along with external experts, will review the Company\u2019s numerous ongoing and planned trials in rare pulmonary diseases, and highlight Acceleron\u2019s vision and strategy for long-term growth. Guest Presenters: Mardi &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-501628","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 &#8211; Event to be webcast on Tuesday, June 22 at 8:00 a.m. EDT &#8211; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced it will host a Virtual R&amp;D Day for analysts and investors on June 22, 2021. The virtual event will take place from 8:00 a.m. to approximately 11:00 a.m. EDT. Members of the Acceleron leadership team, along with external experts, will review the Company\u2019s numerous ongoing and planned trials in rare pulmonary diseases, and highlight Acceleron\u2019s vision and strategy for long-term growth. Guest Presenters: Mardi &hellip; Continue reading &quot;Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-08T11:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021\",\"datePublished\":\"2021-06-08T11:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/\"},\"wordCount\":577,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/\",\"name\":\"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-06-08T11:04:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/","og_locale":"en_US","og_type":"article","og_title":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 - Market Newsdesk","og_description":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 &#8211; Event to be webcast on Tuesday, June 22 at 8:00 a.m. EDT &#8211; CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced it will host a Virtual R&amp;D Day for analysts and investors on June 22, 2021. The virtual event will take place from 8:00 a.m. to approximately 11:00 a.m. EDT. Members of the Acceleron leadership team, along with external experts, will review the Company\u2019s numerous ongoing and planned trials in rare pulmonary diseases, and highlight Acceleron\u2019s vision and strategy for long-term growth. Guest Presenters: Mardi &hellip; Continue reading \"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-08T11:04:33+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021","datePublished":"2021-06-08T11:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/"},"wordCount":577,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/","name":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-06-08T11:04:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005186r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-host-virtual-research-and-development-rd-day-on-june-22-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Acceleron to Host Virtual Research and Development (R&amp;D) Day on June 22, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=501628"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501628\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=501628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=501628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=501628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}